Raymond James Financial’s eXoZymes Inc EXOZ Stock Holding History

Raymond James Financial’s Portfolio EXOZ Stock Details EXOZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,000	Closed	-$19.8K	–	6991
2025 Q2	$19.8K	Buy	+2,000	New	+$24.4K	﹤0.01%	5604

Other funds holding EXOZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial's EXOZ Position: Q3 2025 in Review

Raymond James Financial sold out of eXoZymes Inc (EXOZ) in Q3 2025, closing a stake of 2,000 shares — an estimated $19.8K sold.

Raymond James Financial first reported a position in EXOZ in Q2 2025 and held it in 1 quarter. The position peaked at $19.8K in Q2 2025. 6 funds tracked by Wall St. Rank hold EXOZ as of Q3 2025.

Raymond James Financial reported no remaining eXoZymes Inc position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 2,000 eXoZymes Inc shares in Q3 2025, an estimated $19.8K.
Raymond James Financial first reported a position in eXoZymes Inc in Q2 2025 and held it in 1 quarter.
Raymond James Financial's eXoZymes Inc position peaked at $19.8K in Q2 2025.
6 funds tracked by Wall St. Rank held eXoZymes Inc as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.